Literature DB >> 10864880

Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and beta(3)-adrenoceptor knockout mice.

J Oostendorp1, F Preitner, J Moffatt, M Jimenez, J P Giacobino, P Molenaar, A J Kaumann.   

Abstract

The smooth muscle relaxant responses to the mixed beta(3)-, putative beta(4)-adrenoceptor agonist, (-)-CGP 12177 in rat colon are partially resistant to blockade by the beta(3)-adrenoceptor antagonist SR59230A suggesting involvement of beta(3)- and putative beta(4)-adrenoceptors. We now investigated the function of the putative beta(4)-adrenoceptor and other beta-adrenoceptor subtypes in the colon, oesophagus and ureter of wildtype (WT) and beta(3)-adrenoceptor knockout (beta(3)KO) mice. (-)-Noradrenaline and (-)-adrenaline relaxed KCl (30 mM)-precontracted colon mostly through beta(1)-and beta(3)-adrenoceptors to a similar extent and to a minor extent through beta(2)-adrenoceptors. In colon from beta(3)KO mice, (-)-noradrenaline was as potent as in WT mice but the effects were mediated entirely through beta(1)-adrenoceptors. (-)-CGP 12177 relaxed colon from beta(3)KO mice with 2 fold greater potency than in WT mice. The maintenance of potency for (-)-noradrenaline and increase for (-)-CGP 12177 indicate compensatory increases in beta(1)- and putative beta(4)-adrenoceptor function in beta(3)KO mice. In oesophagi precontracted with 1 microM carbachol, (-)-noradrenaline caused relaxation mainly through beta(1)-and beta(3)-adrenoceptors. (-)-CGP 12177 (2 microM) relaxed oesophagi from WT by 61.4+/-5.1% and beta(3)KO by 67.3+/-10.1% of the (-)-isoprenaline-evoked relaxation, consistent with mediation through putative beta(4)-adrenoceptors. In ureter, (-)-CGP 12177 (2 microM) reduced pacemaker activity by 31.1+/-2.3% in WT and 31.3+/-7. 5% in beta(3)KO, consistent with mediation through putative beta(4)-adrenoceptors. Relaxation of mouse colon and oesophagus by catecholamines are mediated through beta(1)- and beta(3)-adrenoceptors in WT. The putative beta(4)-adrenoceptor, which presumably is an atypical state of the beta(1)-adrenoceptor, mediates the effects of (-)-CGP 12177 in colon, oesophagus and ureter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864880      PMCID: PMC1572127          DOI: 10.1038/sj.bjp.0703365

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.

Authors:  M D Pak; P H Fishman
Journal:  J Recept Signal Transduct Res       Date:  1996 Jan-Mar       Impact factor: 2.092

3.  beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.

Authors:  A A Konkar; Y Zhai; J G Granneman
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

4.  Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP.

Authors:  H Lemoine; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

Review 5.  Beta 3 and atypical beta-adrenoceptors.

Authors:  J R Arch; A J Kaumann
Journal:  Med Res Rev       Date:  1993-11       Impact factor: 12.944

6.  Peripheral muscarinic control of norepinephrine release in the cardiovascular system.

Authors:  E Muscholl
Journal:  Am J Physiol       Date:  1980-12

7.  Beta4-adrenoceptors are more effective than beta1-adrenoceptors in mediating arrhythmic Ca2+ transients in mouse ventricular myocytes.

Authors:  N S Freestone; J F Heubach; E Wettwer; U Ravens; D Brown; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-10       Impact factor: 3.000

8.  (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Changes in beta 1- and beta 2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats.

Authors:  J P Revelli; R Pescini; P Muzzin; J Seydoux; M G Fitzgerald; C M Fraser; J P Giacobino
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

10.  [Cardiac beta receptors--experimental aspects].

Authors:  A J Kaumann
Journal:  Z Kardiol       Date:  1983-02
View more
  4 in total

1.  beta(1)-Adrenoceptors compensate for beta(3)-adrenoceptors in ileum from beta(3)-adrenoceptor knock-out mice.

Authors:  D S Hutchinson; B A Evans; R J Summers
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Tools to study beta3-adrenoceptors.

Authors:  Wim Vrydag; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-09       Impact factor: 3.000

3.  Spontaneous contractions augmented by cholinergic and adrenergic systems in the human ureter.

Authors:  Hyun Woo Lee; Cheol Hee Baak; Moo Yeol Lee; Young Chul Kim
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

4.  Uncoupling protein-3 as a molecular determinant of the action of 3,5,3'-triiodothyronine on energy metabolism.

Authors:  Pierre Flandin; Lorenz Lehr; Cedric Asensio; Jean-Paul Giacobino; Françoise Rohner-Jeanrenaud; Patrick Muzzin; Maria Jimenez
Journal:  Endocrine       Date:  2009-07-14       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.